Clinical Trials on Nosocomial Pneumonia in Hungary

Total 73 results

Pfizer

Completed

A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia

Ventilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)

Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
MedImmune LLC
National Institute of Allergy and Infectious Diseases (NIAID); Antibacterial... and other collaborators

Completed

Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects (EVADE)

Pseudomonas Aeruginosa

Spain, United States, Belgium, France, Hungary, United Kingdom, Israel, Austria, Portugal, Greece, Czechia, Turkey, Croatia, Ireland
Semmelweis University

Unknown

Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study.

Ventilator Associated Pneumonia | Antibiotic Resistant Infection

Hungary
Semmelweis University

Unknown

Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients

Corona Virus Infection | Ventilator Associated Pneumonia

Hungary
Szeged University
Budapest University of Technology and Economics; Hochschule Furtwangen University

Completed

PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients

COVID-19 | Atelectasis | Virus; Pneumonia

Hungary
Del-Pest Central Hospital - National Institute...

Recruiting

Extracorporeal Photopheresis as a Possible Therapeutic Approach to Adults With Severe and Critical COVID-19 (COVID-ECP)

COVID-19

Hungary
Semmelweis University

Recruiting

This Study Investigate the Impact of Maternal COVID-19 Infection During Birth on the Childrens' Physical and Mental Development. (Coronababies)

COVID-19

Hungary
Orthosera Kft.
University of Pecs; Semmelweis University; Hungarian National Blood Service; Humán...

Recruiting

Anti COVID-19 Convalescent Plasma Therapy

COVID 19

Hungary
University of Pecs

Terminated

Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary (PROACTIVE-19)

COVID-19 | SARS-CoV-2 | Coronavirus | 2019-nCoV | 2019nCoV

Hungary
SigmaDrugs Research Ltd.

Completed

Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients

Covid19

Hungary
Somogy Megyei Kaposi Mór Teaching Hospital

Enrolling by invitation

Coordination and Locomotor Problems in Patients With Covid-19 Virus

Covid19 | Balance | Motility Disorder

Hungary
BioVersys AG

Recruiting

PK of BV100 in Patients VABP Suspected or Confirmed to be Due to CRAB

Ventilator Associated Pneumonia

Greece, Georgia, Hungary
Szeged University

Unknown

Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19

COVID-19 | Sars-CoV2

Hungary
University of Pecs
Hungarian Ministry of Innovation and Technology; HECRIN Consortium

Completed

Clinical Trial of Favipiravir Treatment of Patients With COVID-19

SARS-CoV-2 Infection

Hungary
University of Pecs
Hungarian Ministry of Innovation and Technology; HECRIN Consortium

Unknown

REMdesivir-HU Clinical Study and Severe Covid-19 Patients

SARS-CoV-2 Infection

Hungary
University of Pecs

Recruiting

Social Workers of Elderly Care in Hungary

COVID-19 | Stress | Burnout, Professional

Hungary
Semmelweis University Heart and Vascular Center
University of Pecs; Semmelweis University; Szeged University; University of Debrecen

Unknown

HUNgarian COronaVirus Disease-19 Epidemiological Research

Coronavirus Infection

Hungary
Semmelweis University

Completed

Safety of Remdesivir Treatment in COVID-19 Patients Requiring Hemodialysis (REM-HD)

Covid19 | End Stage Renal Failure on Dialysis

Hungary
Basilea Pharmaceutica

Completed

Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia

Community-acquired Pneumonia (CAP) | Hospital-acquired Pneumonia (HAP)

Bulgaria, Hungary, Georgia, Romania
Szeged University

Completed

Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population

Coping Skills | Mood | COVID-19 Pandemic | Psychological Stress | Subjective Health Complaint | Questionnaire Designs | Two-Item Generalised Anxiety Disorder Scale | Patient Health Questionnaire Anxiety and Depression Scale | Health Status Index

Hungary
University of Pecs

Recruiting

Interleukin-6 Antagonists in Critically-ill Covid-19 Patients (HEMOCOV)

COVID-19 | Critical Illness

Hungary
University of Debrecen

Completed

Effect of Lung Protective One-lung Ventilation With Fix and Variable PEEP on Oxygenation and Outcome

Pneumonia | Hypoxemia | ARDS, Human | Pulmonary Sepsis

Hungary
University of Debrecen

Completed

Lung Protective One-lung Ventilation With Fix and Variable Tidal Volume

Pneumonia | Hypoxemia | ARDS, Human | Pulmonary Sepsis

Hungary
European Society for Blood and Marrow Transplantation

Completed

A Case-control Study on Risk Factors, Timing, and PCR Use, for Pneumocystis Pneumonia (PcP) After Allogeneic HSCT

Pneumocystis Pneumonia

Belgium, Israel, France, Germany, Hungary, Norway
Centro Medico del Noroeste
Alfasigma S.p.A.

Recruiting

Endothelial Protection in Post COVID-19 Patients With Sulodexide

Thrombosis | Endothelial Dysfunction | Post COVID-19

Hungary, Mexico
Paratek Pharmaceuticals Inc

Active, not recruiting

Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia

Community-acquired Pneumonia | Bacterial Pneumonia

Bulgaria, Croatia, Georgia, Hungary, Poland, Russian Federation, Serbia, Ukraine
Hofseth Biocare ASA
KGK Science Inc.

Completed

Investigation of the Efficacy of CARDIO Softgels PLUS Best-standard-of-care in the Recovery of Patients With COVID-19

Covid-19 | COVID

Canada, Brazil, Hungary, Mexico, Serbia
Furiex Pharmaceuticals, Inc

Terminated

Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia

Community-Acquired Bacterial Pneumonia (CABP)

United States, Canada, Colombia, Germany, Hungary, Poland
Shionogi

Completed

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants

Sepsis | Gram-negative Bacterial Infections | Bloodstream Infections (BSI) | Complicated Intra-abdominal Infection (cIAI) | Hospital Acquired Pneumonia (HAP) | Ventilator-acquired Pneumonia | Complicated Urinary Tract Infection (cUTI)

Spain, Belgium, Latvia, Russian Federation, Estonia, Georgia, Hungary, Thailand, Ukraine
Forest Laboratories
AstraZeneca

Completed

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)

Infections | Community Acquired Pneumonia

Spain, United States, Argentina, Bulgaria, Georgia, Greece, Hungary, Poland, Ukraine
Bayer

Completed

CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized Patients

Pneumonia

Croatia, France, Hungary, Jordan, Kazakhstan, Lebanon, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Romania, Russian Federation, Ukraine
MedImmune LLC
National Institute of Allergy and Infectious Diseases (NIAID); Innovative Medicines... and other collaborators

Completed

Study of the Efficacy and Safety of MEDI4893 (SAATELLITE)

Staphylococcus Aureus Pneumonia

Spain, Belgium, United States, France, Germany, Czechia, Greece, Switzerland, Hungary, Portugal
Forest Laboratories
AstraZeneca

Completed

Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus

Infections

Poland, Romania, Russian Federation, Ukraine, Georgia, Hungary, United States, Spain
Melinta Therapeutics, Inc.
Biomedical Advanced Research and Development Authority

Terminated

Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia

Community-acquired Bacterial Pneumonia

Spain, United States, Philippines, Hungary, United Kingdom, Bulgaria
NEURALIS s.a.

Active, not recruiting

Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection

Covid19

Belgium, Hungary, Russian Federation, Poland
Shionogi

Completed

Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens (APEKS-NP)

Hospital Acquired Pneumonia (HAP) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)

Israel, Spain, United States, Belgium, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Japan, Latvia, Philippines, Puerto Rico, Russian Federation, Serbia, Taiwan, Ukraine
Arsanis, Inc.

Terminated

Prevention of S. Aureus Pneumonia Study in Mechanically Ventilated Subjects Who Are Heavily Colonized With S. Aureus.

Pneumonia, Ventilator-associated | Pneumonia, Staphylococcal

United States, Spain, France, Czechia, Portugal, Israel, Romania, Russian Federation, Hungary, Poland, Ukraine, India, Austria, Georgia, Serbia, South Africa
Pfizer

Terminated

Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia

Pneumonia, Bacterial

Canada, United States, Argentina, Australia, Brazil, Chile, Colombia, Croatia, France, Hungary, Korea, Republic of, Latvia, Russian Federation, Taiwan
Biotest

Recruiting

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia (TRICOVID)

COVID-19 | Pneumonia | Acute Respiratory Distress Syndrome | Community-acquired Pneumonia | Respiratory Infection | Bacterial Pneumonia | Viral Pneumonia | Fungal Pneumonia

Belgium, Brazil, Latvia, Germany, Lithuania, South Africa, Argentina, Austria, France, Hungary, Slovakia, Turkey, Portugal, Spain
Melinta Therapeutics, Inc.

Completed

Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia (DEFINE-CABP)

Community Acquired Bacterial Pneumonia

United States, Argentina, Bulgaria, Colombia, Dominican Republic, Georgia, Germany, Hungary, Latvia, Peru, Poland, Romania, Russian Federation, Serbia, Slovenia, South Africa, Spain, Ukraine
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia (SOLITAIRE-ORAL)

Community-acquired Bacterial Pneumonia

Spain, United States, Hungary, Canada, Estonia, Russian Federation, Argentina, Bulgaria, Czech Republic, Dominican Republic, Ecuador, Germany, Latvia, Poland, Puerto Rico, Romania, South Africa
Hoffmann-La Roche

Completed

A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia

Pneumonia, Bacterial

United States, Romania, Chile, Slovakia, Hungary, Bulgaria, Latvia, Croatia, Peru, Lithuania, Argentina
MetrioPharm AG
Syneos Health, LLC

Completed

MP1032 Treatment in Patients With Moderate to Severe COVID-19

COVID-19

Spain, United States, Italy, France, Bulgaria, Hungary, Romania
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated Pneumonia

Ventilator-Associated Pneumonia

United States, Australia, Germany, France, Spain, Argentina, Mexico, Portugal, India, Romania, Turkey, Ukraine, Canada, Belgium, Brazil, Philippines, Russian Federation, Hungary, Israel, Thailand, Guatemala
Forest Laboratories

Completed

Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia (CAP)

Bacterial Pneumonia

United States, Argentina, Austria, Bulgaria, Chile, Germany, Hungary, India, Latvia, Mexico, Peru, Poland, Romania, Russian Federation, Ukraine
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia

COVID-19 Pneumonia, Impaired Respiratory Function

Germany, India, Spain, Russian Federation, Mexico, Netherlands, Peru, Brazil, Hungary, Argentina, Denmark, South Africa
AbbVie

Completed

Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)

CoronaVirus Disease-2019 (COVID-19)

United States, Hungary, Israel, Netherlands, Puerto Rico
Entasis Therapeutics

Completed

Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex (ATTACK)

Bacteremia | Ventilator-associated Bacterial Pneumonia | Acinetobacter Baumannii-calcoaceticus Complex | Hospital-acquired Bacterial Pneumonia | Colistin Resistant ABC

United States, Belarus, Brazil, China, Greece, Hungary, India, Israel, Korea, Republic of, Lithuania, Mexico, Peru, Puerto Rico, Russian Federation, Taiwan, Thailand, Turkey
Cardeas Pharma

Completed

Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia (IASIS)

Pneumonia, Bacterial

Spain, United States, Greece, Hungary, Turkey, Puerto Rico, France
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia (SOLITAIRE-IV)

Community-acquired Bacterial Pneumonia

Spain, United States, Philippines, Taiwan, Canada, Germany, Poland, Russian Federation, Argentina, Bulgaria, South Africa, Slovenia, Serbia, Colombia, Hungary, Netherlands, Slovakia, Ukraine, Peru, Latvia, Guatemala, Romania, Chile, G... and more

Clinical Trials on Nosocomial Pneumonia in Hungary

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations